Predictive Multiomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cannaponics to Provide GATC Health’s Medical Cannabis Testing Platform to Patients & Physicians Throughout Australia Australian firm takes the lead in genetics and AI-based technology for personalized medical cannabis treatments IRVINE, Calif.--(BUSINESS WIRE)--#biopharma--GATC Health, an innovative technology company focused on whole genome testing and Predictive Multiomics™, today announced that its Medical Cannabis platform licensee, GATC Canna, has entered into an agreement with Cannaponics, an integrated medicinal cannabis company based in Australia. The agreement allows Cannaponics ...

Global Capital Network (GCN) features GATC Health as medtech impact brand to consider as a strategic partner for Family Offices, Angel Investors, Venture Capital & PE Share Article Recently, GATC & Liquid Biosciences signed a partnership agreement that combines Liquid Biosciences’ evolutionary math and GATC’s artificial intelligence focused on predictive multiomics known as Multiomics Advanced Technology™ Next Generation Medtech Platform This impactful medical AI technology and JV can significantly reduce drug development costs & personalize healthcare. We want to highlight it as a stra...